Aktiesnakken — December 2009
-
ok thanx
-
-
du kan finde det i den grå boks.... det hedder noget med 1989
-
tror da ikke vi har hørt om det?
-
Ofatumumab is somewhat more potent than Rituxan, that should help.
-
Den fremgår af clinicaltrials.com. Firtst received 1/12-09. http://www.clinicaltrials.gov/ct2/show/NCT01024010?term=arzerra&rank=2
-
hvorfor står der Mayo clinic?
-
det er toppen af poppen indenfor hospitaler..... men burde der ikke stå genmab eller gsk?
-
vi har da ikke fået det oplyst har vi det? eller er det bare druknet i bleer og almen tristesse
-
det er bare en reference til mayo clinic
-
en partneraftale med dr.oetker kunne dog nok øge salget en del...
-
omkring det andet stof virkning på immun
-
ok
-
Coller, I de af Dahanca sponsorede forsøg med Zalut er Genmab heller ikke nævnt. http://www.clinicaltrials.gov/ct2/show/NCT00496652?term=dahanca&rank=3
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind